Skip to main content
. 2020 Jun 1;4:9. doi: 10.1186/s41824-020-00078-8

Fig. 5.

Fig. 5

Silhouette results among relapsing/refractory patients. Patient-wise silhouette among relapsing/refractory patients with lymph nodal (a) and all (b) lesions. Variations of patient-wise silhouette with/without extra-nodal lesions (c)